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Abstract
Background: Importance of Toxoplasma gondii for humans refers mainly to primary infection in 
pregnant women and also infection in immunocompromised individuals. Aim: The current study 
aimed to determine the seroprevalence of toxoplasmosis in pregnant women in Fars province, 
southern Iran, and to find out the chronic and acute cases of toxoplasmosis in this population 
with molecular and serological methods. Subjects and Methods: Blood samples were taken from 
2000 pregnant women, admitted to Shiraz university-affiliated hospitals in 2014 and serum and 
buffy coat were separated. Data such as age, number of pregnancy, pregnancy age and place of 
resident were recorded for each participant. Sera samples were evaluated for anti-Toxoplasma 
IgG and IgM, using a commercial ELISA kit. Moreover, the seropositive cases were evaluated 
by PCR to amplify a 529bp gene of Toxoplasma gondii. Results: Anti-Toxoplasma antibodies were 
detected in sera of 177 (8.9%) of cases. From these, 172 (8.6%) were seropositive only for IgG, 4 
(0.2%) were seropositive only for IgM and 1 (0.05%) were positive for both IgG and IgM. PCR 
detected Toxoplasma DNA in buffy coat of 15 out of 177 (8.5%) of the seropositive subjects, two of 
them were IgM positive and the remaining 13 were among IgG seropositive cases. Conclusion: 
Findings of this study demonstrated a relatively low rate of seropositivity for toxoplasmosis in 
pregnant women in the area. This means that a high percentage of pregnant women are at risk of 
acquiring toxoplasmosis during their pregnancy and subsequently, transmission of the infection 
to their fetus. 
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Introduction
Toxoplasma gondii is a cosmopolitan zoonotic protozoan 
which can infect many of warm blooded animals such as birds, 
mammals, and human.[1] Rate of human infection in different 
areas of the world is different due to variation in nutritional diets 
of the people, weather condition and reservoir hosts.
Infections with toxoplasmosis usually cause a mild disease in 
immunocompetent individuals and severe and life threatening 
infection in immunocompromised patient. The most serious 
manifestation of the disease can be seen in congenital 
toxoplasmosis, resulting from vertical transmission of the 
parasite during pregnancy.[2-4] Seroprevalence of toxoplasmosis 
in women at childbearing age varies in different geographical 
areas of Iran and ranged from 5 up to 70%. [5]
A prevalence rate of 55.5% has been reported form toxoplasmosis 
among pregnant women in north of Iran while this rate has been 
reported to be 29.3% in Khuzestan, south of Iran, with a different 
weather condition.[6-7] Fallah et al. reported a seroprevalence of 
33.5% for Toxoplasma in pregnant women in 2004 in Hamedan, 
western Iran.[8] A seroprevalence rate of 34% was reported 
for anti-Toxoplasma antibodies in pregnant women from 
Qazvin, in northwest of Iran.[9] Mostafavi et al. documented a 
seroprevalence of 47% in pregnant women in Isfahan, central 
Iran, and Davami et al. reported a seroprevalence of 15% for 
toxoplasmosis for women who referred to clinical laboratories 
for pre-marriage testing.[10,11]
It has been documented that Toxoplasma DNA can be detected 
in the buffy coat of individual during acute toxoplasmosis.[12] 
This might be a very useful approach for diagnosis of acute 
toxoplasmosis in pregnant women, where defining the acute 
infection in crucial for implementation of appropriate therapy 
and prevention measurements. 
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The current study aimed to determine the seroprevalence of 
toxoplasmosis in pregnant women in Fars province, southern 
Iran, and to find out the chronic and acute cases of toxoplasmosis 
in this population with molecular and serological methods.
Subjects and Methods
Study population
The current study was conducted in 2014 in Fars province, 
southern Iran [Figure 1]. After getting approval from the ethics 
committee of Shiraz University of Medical Sciences, blood 
samples were taken from 2000 pregnant women admitted to 
Shiraz university-affiliated hospitals. Sample size was calculated 
based on the prevalence of toxoplasmosis in the region, using 
SPSS software (version 18, SPSS, Chicago). Demographic 
features and also number of pregnancy, pregnancy age and place 
of resident were recorded for each participant. 
Serological tests
Sera were obtained from the whole blood of each participant. 
Moreover, buffy coat was obtained from each blood sample for 
subsequent molecular study. Samples were transferred to the 
serology laboratory at department of parasitology and mycology 
in Shiraz University of Medical Sciences, Shiraz, Iran, and 
kept at -20°C until use. All of sera samples were evaluated for 
anti-Toxoplasma IgG and IgM antibodies, using a commercial 
enzyme immunoassay kit (Pishtaz Teb Diagnostics, Tehran, 
Iran).
Molecular analysis
The seropositive cases (either IgG or IgM) were evaluated by 
PCR to detect Toxoplasma DNA in the buffy coats. DNA was 
extracted from the buffy coat of each sample, using phenol 
chloroform method. PCR was performed to amplify a 529 bp 
gene of T. gondii, as described by Edvinsson et al. using each of 
two primers, TOXOF CAGGGAGGAAGACGAAAGTTG and 
TOXOR CAGACACAGTGCATCTGGATT.[13]
Statistical analysis of the data
Collected data were analyzed by SPSS software (version 18, 
SPSS, Chicago). Fisher exact test and chi-square were used to 
compare the seroprevalence values related to the features of the 
subjects.
Results
The pregnant women being studied were aged from 15 to 45 
years old with mean age of 27.4 years. Most of the participants 
(35.4%) were aged 25-30 years old and the lowest (1.2%) were 
in the age group of 40 or higher. Most of pregnant women 
(57.3%) were in the second trimester of their pregnancy. Anti T. 
gondii antibodies were detected in the sera of 177 out of 2000 
pregnant women, corresponding to an overall seroprevalence of 
8.9% in this population. Of these, 172 (8.6%) were seropositive 
for only IgG, 4 (0.2%) were seropositive for only IgM and 1 
(0.05%) was positive for both IgG and IgM.
Most of the seropositive cases (36.2%) were younger than 
25 years old and the lowest (1.1%) were aged higher than 40 
years old. Chi square test was used to find out the statistical 
association between seropositivity with number of pregnancy, 
trimesters of pregnancy, and age of the participants. There were 
a significant association between seropositivity and number 
and also trimesters of pregnancy of the participants (p<0.01). 
Most of IgM positive cases (0.3%) were seen in the age group 
of 15-30 years old whereas pregnant women aged 30-35 years 
had the lowest rate of IgM seropositivity. Correlation between 
IgM positivity and number of pregnancy or trimester were not 
statistically significant (p=0.18). All of seropositive cases were 
tested for the presence of T. gondii DNA in their buffy coat 
samples. Molecular study revealed a 529bp band of T. gondii in 
peripheral blood of 15 out of 177 (8.5%) seropositive pregnant 
women [Figure 2]. Two of these cases were IgM positive and 
the remaining 13 cases were among the IgG seropositive cases. 
Table 1 shows the demographic features of pregnant women and 
relative seropositivity to T. gondii in this study.
Figure 1: Map of Iran and location of Fars province (Dark red)
Figure 2: PCR product of 529 bp gene of T. gondii isolated from 
buffy coat of a few of pregnant women. Lane 1: negative control, 
Lane 2-11: samples isolated from the buffy coat of pregnant women, 
Lane 12: positive control (strain Rh of T. gondii (type I)), lane 13: 
Molecular marker
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risk of transplacental transmission. This is not always the case 
since IgM may persist as long as one year in sera of toxoplasmic 
patients. Therefore, other serological methods might be used to 
find out the estimate time of infection. Detection of Toxoplasma 
DNA in the buffy coat of the seropositive individuals may be 
related to acute infection. In a recent study in Fars province, 
south of Iran, 1500 cases of blood donors were evaluated for anti-
Toxoplasma antibodies and 5.4% of the donors were seropositive 
for IgM and 1.6% for both IgG and IgM. Toxoplasma DNA has 
been detected in blood samples of two of IgM positive cases of 
blood donors but not in the buffy coat of the rest of seropositive 
cases.[14] In another study conducted on patients undergoing 
chemotherapy for malignancies in the Bushehr Province, 
Southwest Iran, T. gondii DNA was detected in the buffy coats 
of two out of 86 (2.3%) cases.[19] In the current study IgM anti-
Toxoplasma antibody were detected in the sera of 5 (0.25%) 
of pregnant women while PCR detected Toxoplasma DNA in 
the buffy coat of 15 (0.75%) of the seropositive subjects, two 
of them were IgM positive and the remaining 13 were among 
IgG seropositive cases. Based on these findings, detection of 
Toxoplasma DNA in the buffy coat may not necessary indicate 
an acute infection. Moreover, presence of Toxoplasma DNA in 
the blood of IgM negative cases might be related to the false 
negativity of IgM result. 
Taken together findings of this study showed that a low number of 
pregnant women in Fars province, southern Iran, are seropositive 
for toxoplasmosis. This indicates that high percentages of 
pregnant women are at risk of acquiring toxoplasmosis during 
their pregnancy and subsequent transmission of the infection to 
their fetus. Furthermore, in this study, molecular findings had no 
relationship with acute toxoplasmosis in studied cases. Further 
study, with large number of IgM positive cases, is needed to 
explore the value of PCR detection of Toxoplasma DNA in 
buffy coat for diagnosis of acute toxoplasmosis.
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Discussion
Toxoplasmosis is a common parasitic infection of human 
and animals throughout the world, including Iran.[1,4,10,14] The 
overall seroprevalence rate of toxoplasmosis among the general 
population in Iran was reported to be 39.3%.[5]
In the current study seropositive rate of toxoplasmosis in 
pregnant women was found to be 8.8%, in southern Iran. This 
rate of seroprevalence in pregnant women is more or less 
similar to the rates reported in other studies conducted on child 
bearing and pregnant women in southern part of the country but 
lower than those reported from north part of the country.[6,7,9,15] 
Rate of Toxoplasma infection in north part of the country, where 
the temperature is ambient for survival of Toxoplasma oocyst 
excreted by the cat, is higher in comparison to the southern and 
western part of the country.[6,7,16] 
Keeping cats and dogs as pets are not so common in Fars 
province in Iran. However, the number of stray cats and dogs 
are significant and stray cats, in this case, pose a major threat 
to human health through their role as reservoirs of Toxoplasma. 
Consumption of contaminated vegetables might be the main 
source of Toxoplasma infection in pregnant women since in 
Iran women are usually clean and wash the vegetables at home 
and they may contaminate themselves while cleaning the 
vegetables. However, high seroprevalence of toxoplasmosis in 
meat producing animals in the region indicates that transmission 
may be occurring through consumption of undercooked meats 
of farm animals, as likely as contaminated vegetables.[17,18] 
In the current study, rate of seropositivity was increased 
with pregnancy number where seropositivity was higher in 
multigravidae than in primigravidae. This is probably related to 
the age of the subjects rather than number of pregnancy, since 
the rate of seropositivity to Toxoplasma usually increase with 
the age. 
The presence of IgM anti-Toxoplasma antibodies reflects the 
Table 1: Demographic features of pregnant women and relative seropositivity to T. gondii in Fars province, southern Iran
Characteristics Frequency Percent (%) Positive for anti-Toxoplasma antibodies (either IgG or IgM) P Value
No %
Age Group (Year)
<25 689 34.5 64 9.3 0.16
25-30 707 35.4 54 7.6
31-35 448 22.4 38 8.5
36-40 132 6.6 19 14.4
>40 24 1.2 2 8.3
Pregnancy Age
First Trimester 23 1.2 6 26.1 < 0.01
Second Trimester 1146 57.3 139 12.1
Third Trimester 831 41.6 32 3.9
Pregnancy Term
First 1030 51.5 109 10.6 < 0.01
Second 885 44.3 56 6.3
Third 77 3.9 11 14.3
Fourth 7 0.4 1 14.3
Fifth 1 0.1 0 0
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